High performance liquid chromatographic determination of topiramate in human serum using UV detection.
Topiramate has no ultraviolet, visible or fluorescence absorption. Analysis of the drug in human serum has been reported by high performance liquid chromatography (HPLC) with either mass detector or fluorescence detection after precolumn derivatization using 9-fluorenylmethyl chloroformate as fluorescent labeling agent. This study was aimed to validate derivatization and analysis of topiramate in human serum with HPLC using UV detection. The drug was extracted from human serum by liquid-liquid extraction and subjected to derivatization with 9-fluorenylmethyl chloroformate. Analysis was performed on a phenyl column using of spectrophotometer detection operated at wavelength of 264 nm. A mixture of phosphate buffer (0.05M) containing triethylamine (1 ml/l, v/v; pH 2.3) and methanol (28:72, v/v) at a flow rate of 2.5 ml/min was used as mobile phase. No interference was found with endogenous substances. Validity of the method was studied and the method was precise and accurate with a linearity range from 40 ng/ml to 40 microg/ml. The limit of quantification was 40 ng/ml of serum. The correlation coefficient between HPLC methods using fluorescence and UV detections was studied and found to be 0.992.
Medical Biology Research Center, Medical School, Kermanshah University of Medical Sciences, Kermanshah 6714869914, Iran. gbahrami@kums.ac.ir
Gholamreza
G
Bahrami
Shahla
S
Mirzaeei
Bahareh
B
Mohammadi
Amir
A
Kiani
D002851:Chromatography, High Pressure Liquid / Q000379:methods*; D005449:Fluorenes / Q000737:chemistry; D005632:Fructose / Q000031:analogs & derivatives* / Q000097:blood; D006801:Humans; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity; D000077236:Topiramate; D014466:Ultraviolet Rays
D005449:Fluorenes; D000077236:Topiramate; D005632:Fructose; C054007:1-(9-fluorenyl)methyl chloroformate